Supplemental Figures 1-4.tif
Intraduodenal Administration of Reg3g Improves Gut Barrier Function and Mitigates Hepatic Steatosis in Mice
Funding
Intestinal Reg3g as a mediator of dietary, pharmacological and surgical therapies for obesity and diabetes
National Institute of Diabetes and Digestive and Kidney Diseases
Find out more...Michigan Nutrition Obesity Research Center
National Institute of Diabetes and Digestive and Kidney Diseases
Find out more...Gut-brain axis in metabolic disease
National Institute of Diabetes and Digestive and Kidney Diseases
Find out more...University of Michigan Center for Gastrointestinal Research
National Institute of Diabetes and Digestive and Kidney Diseases
Find out more...The role of intestinal-derived FGF15/19 during obesity and rapid weight loss
United States Department of Veterans Affairs
Find out more...